Imperial College London is consistently ranked amongst the top 10 Universities in the world. It is one of the largest Universities in Europe, and it is truly international, with 17,000 students from 125 countries, and 8,000 staff, 50% from outside the UK. Imperial College London focuses on 4 main disciplines, science, engineering, medicine, and business. The Imperial College London Academic Health Sciences Centre brings together interdisciplinary research efforts linking clinical medicine with science, technology and engineering focused on health problems. Imperial College London has world renowned expertise in the application of omics technologies to health; and in computational biology, linking mathematics, statistics and computer science. The core concepts developed in the DIAMONDS proposal arise from linking the molecular and computational strengths within the College. Imperial College London also has an international reputation for leadership in clinical research, observational studies and clinical trials, and project management. The DIAMONDS project links the research excellence in medicine, computational biology and molecular biology within Imperial College London.
Imperial College London is the Coordinating Centre for DIAMONDS. Between groups working in the Department of Infectious Disease (led by Prof Mike Levin), the Department of Electronic Engineering (led by Dr Pantelis Georgiou), and Research Impact Management Office (led by Dr Marta Archanco), Imperial College London will undertake:
To learn more about our team and research areas, please use the below links:
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 848196